While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...

Sen. Josh Hawley, R-Mo., demanded Tuesday that Congress move to stop insurance companies from owning pharmacy benefit ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

Gov. Gavin Newsom will seek to regulate pharmaceutical middlemen that he blames for driving up prescription drug costs in ...

Gov. Gavin Newsom announced today that he will seek to regulate prescription drug middlemen that he blames for driving up ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

UnitedHealth remains in fine financial shape. As of December 2024, the company owed $77 billion in debt (held at the parent level), or gross debt/EBITDA of around 2 times. The parent company typically ...

The Most Favored Nations directive would allow drugmakers to directly sell their products to patients at a lower cost, ...

SAN ANTONIO — Today, President Trump signed an executive order aiming to cut prescription drug prices for Medicare. The order ...

Pharmacology has been at it a long time. Precursor to the Western pill-based prescription for all that ails, it stands on the shoulders of a thousands-generations long compilation of the knowledge of ...

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Biocon Biologics has secured multiple market access agreements for Yesintek (ustekinumab-kfce), its biosimilar to Stelara ...